NEWS Therapeutic Solutions International Initiates 500

New Post Public Reply Private Reply Replies (0) Message Board
stock-scamper
211
NEWS
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™
San Diego Top Doctor James Veltmeyer Leads Efforts to Demonstrate Efficacy of Immune Boosting Formulation in High-Risk Population
OCEANSIDE, California, June 8, 2020 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced the initiation of a clinical trial aimed at demonstrating safety and efficacy of its immune-boosting formulation QuadraMune™.

The trial is anticipated to recruit 500 subjects at risk of SARS-CoV-2 infection, the type of coronavirus which causes COVID-19.

The new clinical trial has been granted ClinicalTrials.gov Identifier: NCT04421391 and is expected to appear on the Federal Clinical Trial registry this week.

Last week the Company announced data from a preliminary clinical trial in which four groups of eight volunteers were treated with placebo or escalating doses of QuadraMune™[1]. Elevation of innate immune response activity was observed, together with a decreased responsiveness towards inflammatory stimuli. These preliminary data were analyzed by the Company's Scientific Advisory Board, who then recommended proceeding to the larger trial.

"At Therapeutic Solutions International we believe only in hard science. As a medical doctor who is on the frontlines of the war with Coronavirus, I and my staff take QuadraMune™ daily," said James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International and "Top Doctor" of San Diego in 2012, 2014, 2016, 2017, and 2019. "The laboratory and early clinical results seen with QuadraMune™ are truly inspiring. We believe the time has come to jump into a large clinical trial to generate the data necessary to truly convince our colleagues and the world of the potential efficacy of this immune-stimulatory and anti-inflammatory approach."

The clinical trial calls for the daily administration of QuadraMune™ for a period of twelve weeks. Rates of infection will be assessed compared to controls. Subjects eligible to enter the trial are high-risk individuals, which are defined as all health care workers in hospitals, clinics, and emergency rooms, and medical facilities.

"If you look historically at pandemics, almost all of them have a Second Wave, which is almost always substantially more devastating than the first. We at Therapeutic Solutions International are pleased to apply our work in the area of inflammation and immune stimulation, to attempt to add another arrow in our quiver against this invisible enemy," said Timothy Dixon, President, and CEO of Therapeutic Solutions International. "In some ways, Coronavirus is like cancer…you want to increase activation of innate immunity and suppress inflammatory reactions simultaneously. We have been doing this research successfully using NanoStilbene™ in cancer, and now we are transposing our findings into the field of virology."

A pre-publication copy, of the submitted manuscript of the preliminary clinical trial, is available by following this link: https://therapeuticsolutionsint.com/CV/JTRM-D-20-01014.pdf.

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one's immune system. The Company's corporate website is at www.therapeuticsolutionsint.com and our e-commerce is at www.youcanordernow.com and for additional info on QuadraMune™ visit www.areyoucovidmune.com/covidmune/.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

1. https://www.biospace.com/article/releases/the...-covid-19/

Company Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™
Contact:
Timothy Dixon
+1-(760)-295-7208
Therapeutic Solutions International, Inc.
ir@tsoimail.com

https://c212.net/c/img/favicon.png?sn=LN28035...2020-06-08 View original content:http://www.prnewswire.com/news-releases/therapeutic-solutions-international-initiates-500-volunteer-covid-19-prevention-clinical-trial-using-quadramune-301071981.html

SOURCE Therapeutics Solutions International, Inc.

Progressive Insurance
Sponsored By: Progressive Insurance
Save extra just by protecting your home and car together! Get a FREE Quote

Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filings

Pink Current Information

DAILY ADVANCERS
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Enter your email
SIGN UP
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FirstService Jolts Mira Mar Redesign Masterplan

Updated Category News Views 83

Sarasota's Mira Mar Finds Its Match Holy smokes! Sarasota's making waves again as Mira Mar, the high-end luxury condominium development, ropes in FirstService Residential to give it that extra oomph. Now, we're talkin’ about a real shake-up in downtown Sarasota real estate. The game here isn’t just grabbing a slice of the pie; it's the whole damn pie. Luxury Living...

Continue Reading
HSBC Boosts Tender Offer: Capital Management Maneuver

Updated Category News Views 31

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

Continue Reading
Pharmaceutical Navigator ASTHO's Podcast Earns Bronze Anthem Award

Updated Category News Views 99

An Award to Nod At: ASTHO's Public Health Triumph The world of public health isn't generally where you'd find shiny accolades flying around, but when they do, it's worth taking notice. Recently, ASTHO’s podcast, the Public Health Review Morning Edition, snagged a Bronze Anthem Award. Sure, it isn't the gold trophy, but in this high-stakes arena, any medal's a feat! More...

Continue Reading
Savor This Holiday: Apple Cinnamon Martinis Shine Bright

Updated Category News Views 122

A Twist on Tradition for the Holidays Forget about slaving at the bar this holiday season because Rancho La Gloria's coming through with a real game-changer. They're rolling out their new Apple Cinnamon Martini just in time to take your holiday festivities up a notch or two. We're talking 13.9% ABV, folks. That's no sipper from a juice box—this cocktail's got backbone,...

Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss

Updated Category News Views 90

Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...

Continue Reading
Workday: Dominating Cloud ERP with AI Prowess in 2026

Updated Category News Views 106

Workday: A Force in the Cloud ERP Arena Right on! Workday's making waves again in the world of Cloud ERP. In a move that seems to defy the competition, they've locked down their spot as a Leader in the 2026 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for the fifth year running. Consistency isn’t a coincidence here, folks—this is pure strategy!...

Continue Reading
FX's Game-Changer: Stemless Reverse Shoulder System

Updated Category News Views 80

Stirring Up the Shoulder Market You gotta hand it to FX Shoulder Solutions – they've managed to elbow their way into the medical device market with something truly revolutionary. With the FDA clearance of Easytech Reversed®, a stemless reverse shoulder arthroplasty system, they're not just playing the innovation game; they're setting a whole new rulebook. This isn't...

Continue Reading
Puori Unveils Electrolytes+ for Everyday Hydration

Updated Category News Views 69

A Refreshing Take on Electrolytes Pulling no punches, Puori's latest concoction, Electrolytes+—that’s “plus” for potent—has landed with a splash, aiming to flip the electrolyte game on its head. Forget the tired sports drink shtick of sugar-packed, sodium-laden swills—this one's all about keeping you balanced whether you're busting a sweat or just living that...

Continue Reading
BILDTRAK G1 Hits Car Kit Market With Factory Five Deal

Updated Category News Views 71

Paving the Road for Precision in Car Kits How about this for a twist in the automotive world? Starting 2027, Factory Five Racing isn't just handing over boxes of parts and a manual to eager builders. They're tossing in a weapon of precision—the BILDTRAK G1. Quite the move, and frankly, it’s about time someone thought of a way to make DIY car building smoother and,...

Continue Reading
Beetles Gel Polish Debuts Bold Halloween Nail Kit

Updated Category News Views 67

Diving Deep into Beetles Gel Polish's Gothic Launch In a world where nail polish can ignite passions and trends, Beetles Gel Polish is pulling out all the stops with its latest Halloween venture. This ain't your average nail kit, folks. We're talking about the Vampiric Feast Gift Box—an 8-color powerhouse designed to transform your nails into bloody, gothic...

Continue Reading

Top 5 Most Recently Viewed Articles

Comprehensive Overview of SCOR Shares and Voting Rights

Updated Category News Views 217

Understanding SCOR's Share Structure and Voting Rights SCOR, recognized as a leading global reinsurer, plays a crucial role in providing its clients with a remarkable variety of reinsurance and insurance solutions tailored to manage risk effectively. The company's focus on "The Art & Science of Risk" allows SCOR to leverage its widespread expertise alongside innovative...

Continue Reading
PRIDE Industries Champions Inclusive Employment for All

Updated Category News Views 147

PRIDE Industries took a bold step back in October to spotlight National Disability Employment Awareness Month (NDEAM), focusing on ‘Access to Good Jobs for All.’ This ain’t just some PR stunt; it was all about changing the narrative around employing folks with disabilities. Statistics reveal that over 10 percent of working-age Americans have a disability, yet only...

Continue Reading
Eden Collective's Alison Monk Earns Spot on Female Founders 500

Updated Category News Views 430

Eden Collective's Recognition in the Business Landscape Alison Monk, the dynamic CEO and Founder of Eden Collective, has garnered significant attention by being named to the esteemed Female Founders 500 list. This recognition shines a light on the incredible impact women are making across various industries. Speaking of leadership, Alison's journey demonstrates how...

Continue Reading
Jennifer Laucirica Elevates Trusts & Estates Leadership at Rubin Rudman

Updated Category News Views 134

Jennifer Laucirica Takes Co-Chair Role at Rubin Rudman Rubin Rudman proudly announces that Jennifer Laucirica has stepped into the position of Co-Chair of the Trusts & Estates Department. Laucirica joins current Co-Chair Dana Lewis to lead this influential department that has shown remarkable growth in recent years. Experience and Expertise Jennifer Laucirica offers an...

Continue Reading
Siili Solutions Reports Impactful Growth in AI Solutions

Updated Category News Views 210

Overview of Siili Solutions Plc Siili Solutions Plc has designated itself as a leading force in the realm of AI-driven digital advancements. Catering to clients eager to leverage digital transformation for heightened efficiency, competitiveness, and growth, Siili Solutions has made a robust impact since its establishment in 2005. Operative primarily in Finland, the...

Continue Reading